Selected research
Industry Growth & Trends
Global Irreversible Electroporation (IRE) Industry Growth and Trends Forecast to 2032
Market perspective
The global Irreversible Electroporation (IRE) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Irreversible Electroporation (IRE) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Irreversible Electroporation (IRE) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Irreversible Electroporation (IRE) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Irreversible Electroporation (IRE) include Acutus Medical, AngioDynamics, Kardium, Pulse Biosciences, Boston Scientific, Hangzhou Nuomao Medical Technology, Medtronic, Johnson & Johnson and Surgnova, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Irreversible Electroporation (IRE) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Irreversible Electroporation (IRE) market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Irreversible Electroporation (IRE) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Irreversible Electroporation (IRE).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Irreversible Electroporation (IRE) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Irreversible Electroporation (IRE) Market by Company
Acutus Medical
AngioDynamics
Kardium
Pulse Biosciences
Boston Scientific
Hangzhou Nuomao Medical Technology
Medtronic
Johnson & Johnson
Surgnova
Nortion
Shineyo Medical
Tianjin Intelligent Health Medical
Irreversible Electroporation (IRE) Segment by Type
Pulsed Field Ablation System
Steep Pulse Ablation System (NanoKnife)
Irreversible Electroporation (IRE) Segment by Application
Tumors
Cardiac Diseases
Irreversible Electroporation (IRE) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irreversible Electroporation (IRE) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Irreversible Electroporation (IRE) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irreversible Electroporation (IRE).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irreversible Electroporation (IRE) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Irreversible Electroporation (IRE) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pulsed Field Ablation System
- Steep Pulse Ablation System (NanoKnife)
Applications
- Tumors
- Cardiac Diseases
Companies covered
- Acutus Medical
- AngioDynamics
- Kardium
- Pulse Biosciences
- Boston Scientific
- Hangzhou Nuomao Medical Technology
- Medtronic
- Johnson & Johnson
- Surgnova
- Nortion
- Shineyo Medical
- Tianjin Intelligent Health Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Irreversible Electroporation (IRE) Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Irreversible Electroporation (IRE) Sales Estimates and Forecasts (2021-2032)
- 1.3 Irreversible Electroporation (IRE) Market by Type
- 1.3.1 Pulsed Field Ablation System
- 1.3.2 Steep Pulse Ablation System (NanoKnife)
- 1.4 Global Irreversible Electroporation (IRE) Market Size by Type
- 1.4.1 Global Irreversible Electroporation (IRE) Market Size Overview by Type (2021-2032)
- 1.4.2 Global Irreversible Electroporation (IRE) Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Irreversible Electroporation (IRE) Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Irreversible Electroporation (IRE) Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Irreversible Electroporation (IRE) Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Irreversible Electroporation (IRE) Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Irreversible Electroporation (IRE) Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Irreversible Electroporation (IRE) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Irreversible Electroporation (IRE) Industry Trends
- 2.2 Irreversible Electroporation (IRE) Industry Drivers
- 2.3 Irreversible Electroporation (IRE) Industry Opportunities and Challenges
- 2.4 Irreversible Electroporation (IRE) Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Irreversible Electroporation (IRE) Revenue (2021-2026)
- 3.2 Global Top Players by Irreversible Electroporation (IRE) Sales (2021-2026)
- 3.3 Global Top Players by Irreversible Electroporation (IRE) Price (2021-2026)
- 3.4 Global Irreversible Electroporation (IRE) Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Irreversible Electroporation (IRE) Major Company Production Sites & Headquarters
- 3.6 Global Irreversible Electroporation (IRE) Company, Product Type & Application
- 3.7 Global Irreversible Electroporation (IRE) Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Irreversible Electroporation (IRE) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Irreversible Electroporation (IRE) Players Market Share by Revenue in 2025
- 3.8.3 2025 Irreversible Electroporation (IRE) Tier 1, Tier 2, and Tier 3
4 Irreversible Electroporation (IRE) Regional Status and Outlook
- 4.1 Global Irreversible Electroporation (IRE) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Irreversible Electroporation (IRE) Historic Market Size by Region
- 4.2.1 Global Irreversible Electroporation (IRE) Sales in Volume by Region (2021-2026)
- 4.2.2 Global Irreversible Electroporation (IRE) Sales in Value by Region (2021-2026)
- 4.2.3 Global Irreversible Electroporation (IRE) Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Irreversible Electroporation (IRE) Forecasted Market Size by Region
- 4.3.1 Global Irreversible Electroporation (IRE) Sales in Volume by Region (2027-2032)
- 4.3.2 Global Irreversible Electroporation (IRE) Sales in Value by Region (2027-2032)
- 4.3.3 Global Irreversible Electroporation (IRE) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Irreversible Electroporation (IRE) by Application
- 5.1 Irreversible Electroporation (IRE) Market by Application
- 5.1.1 Tumors
- 5.1.2 Cardiac Diseases
- 5.2 Global Irreversible Electroporation (IRE) Market Size by Application
- 5.2.1 Global Irreversible Electroporation (IRE) Market Size Overview by Application (2021-2032)
- 5.2.2 Global Irreversible Electroporation (IRE) Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Irreversible Electroporation (IRE) Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Irreversible Electroporation (IRE) Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Irreversible Electroporation (IRE) Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Irreversible Electroporation (IRE) Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Irreversible Electroporation (IRE) Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Irreversible Electroporation (IRE) Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Acutus Medical
- 6.1.1 Acutus Medical Company Information
- 6.1.2 Acutus Medical Business Overview
- 6.1.3 Acutus Medical Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Acutus Medical Irreversible Electroporation (IRE) Product Portfolio
- 6.1.5 Acutus Medical Recent Developments
- 6.2 AngioDynamics
- 6.2.1 AngioDynamics Company Information
- 6.2.2 AngioDynamics Business Overview
- 6.2.3 AngioDynamics Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 AngioDynamics Irreversible Electroporation (IRE) Product Portfolio
- 6.2.5 AngioDynamics Recent Developments
- 6.3 Kardium
- 6.3.1 Kardium Company Information
- 6.3.2 Kardium Business Overview
- 6.3.3 Kardium Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Kardium Irreversible Electroporation (IRE) Product Portfolio
- 6.3.5 Kardium Recent Developments
- 6.4 Pulse Biosciences
- 6.4.1 Pulse Biosciences Company Information
- 6.4.2 Pulse Biosciences Business Overview
- 6.4.3 Pulse Biosciences Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pulse Biosciences Irreversible Electroporation (IRE) Product Portfolio
- 6.4.5 Pulse Biosciences Recent Developments
- 6.5 Boston Scientific
- 6.5.1 Boston Scientific Company Information
- 6.5.2 Boston Scientific Business Overview
- 6.5.3 Boston Scientific Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Boston Scientific Irreversible Electroporation (IRE) Product Portfolio
- 6.5.5 Boston Scientific Recent Developments
- 6.6 Hangzhou Nuomao Medical Technology
- 6.6.1 Hangzhou Nuomao Medical Technology Company Information
- 6.6.2 Hangzhou Nuomao Medical Technology Business Overview
- 6.6.3 Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Product Portfolio
- 6.6.5 Hangzhou Nuomao Medical Technology Recent Developments
- 6.7 Medtronic
- 6.7.1 Medtronic Company Information
- 6.7.2 Medtronic Business Overview
- 6.7.3 Medtronic Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Medtronic Irreversible Electroporation (IRE) Product Portfolio
- 6.7.5 Medtronic Recent Developments
- 6.8 Johnson & Johnson
- 6.8.1 Johnson & Johnson Company Information
- 6.8.2 Johnson & Johnson Business Overview
- 6.8.3 Johnson & Johnson Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Johnson & Johnson Irreversible Electroporation (IRE) Product Portfolio
- 6.8.5 Johnson & Johnson Recent Developments
- 6.9 Surgnova
- 6.9.1 Surgnova Company Information
- 6.9.2 Surgnova Business Overview
- 6.9.3 Surgnova Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Surgnova Irreversible Electroporation (IRE) Product Portfolio
- 6.9.5 Surgnova Recent Developments
- 6.10 Nortion
- 6.10.1 Nortion Company Information
- 6.10.2 Nortion Business Overview
- 6.10.3 Nortion Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Nortion Irreversible Electroporation (IRE) Product Portfolio
- 6.10.5 Nortion Recent Developments
- 6.11 Shineyo Medical
- 6.11.1 Shineyo Medical Company Information
- 6.11.2 Shineyo Medical Business Overview
- 6.11.3 Shineyo Medical Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Shineyo Medical Irreversible Electroporation (IRE) Product Portfolio
- 6.11.5 Shineyo Medical Recent Developments
- 6.12 Tianjin Intelligent Health Medical
- 6.12.1 Tianjin Intelligent Health Medical Company Information
- 6.12.2 Tianjin Intelligent Health Medical Business Overview
- 6.12.3 Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Product Portfolio
- 6.12.5 Tianjin Intelligent Health Medical Recent Developments
7 North America by Country
- 7.1 North America Irreversible Electroporation (IRE) Sales by Country
- 7.1.1 North America Irreversible Electroporation (IRE) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Irreversible Electroporation (IRE) Sales by Country (2021-2026)
- 7.1.3 North America Irreversible Electroporation (IRE) Sales Forecast by Country (2027-2032)
- 7.2 North America Irreversible Electroporation (IRE) Market Size by Country
- 7.2.1 North America Irreversible Electroporation (IRE) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Irreversible Electroporation (IRE) Market Size by Country (2021-2026)
- 7.2.3 North America Irreversible Electroporation (IRE) Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Irreversible Electroporation (IRE) Sales by Country
- 8.1.1 Europe Irreversible Electroporation (IRE) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Irreversible Electroporation (IRE) Sales by Country (2021-2026)
- 8.1.3 Europe Irreversible Electroporation (IRE) Sales Forecast by Country (2027-2032)
- 8.2 Europe Irreversible Electroporation (IRE) Market Size by Country
- 8.2.1 Europe Irreversible Electroporation (IRE) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Irreversible Electroporation (IRE) Market Size by Country (2021-2026)
- 8.2.3 Europe Irreversible Electroporation (IRE) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Irreversible Electroporation (IRE) Sales by Country
- 9.1.1 Asia-Pacific Irreversible Electroporation (IRE) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Irreversible Electroporation (IRE) Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Irreversible Electroporation (IRE) Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Irreversible Electroporation (IRE) Market Size by Country
- 9.2.1 Asia-Pacific Irreversible Electroporation (IRE) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Irreversible Electroporation (IRE) Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Irreversible Electroporation (IRE) Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Irreversible Electroporation (IRE) Sales by Country
- 10.1.1 South America Irreversible Electroporation (IRE) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Irreversible Electroporation (IRE) Sales by Country (2021-2026)
- 10.1.3 South America Irreversible Electroporation (IRE) Sales Forecast by Country (2027-2032)
- 10.2 South America Irreversible Electroporation (IRE) Market Size by Country
- 10.2.1 South America Irreversible Electroporation (IRE) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Irreversible Electroporation (IRE) Market Size by Country (2021-2026)
- 10.2.3 South America Irreversible Electroporation (IRE) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Irreversible Electroporation (IRE) Sales by Country
- 11.1.1 Middle East and Africa Irreversible Electroporation (IRE) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Irreversible Electroporation (IRE) Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Irreversible Electroporation (IRE) Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Irreversible Electroporation (IRE) Market Size by Country
- 11.2.1 Middle East and Africa Irreversible Electroporation (IRE) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Irreversible Electroporation (IRE) Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Irreversible Electroporation (IRE) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Irreversible Electroporation (IRE) Value Chain Analysis
- 12.1.1 Irreversible Electroporation (IRE) Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Irreversible Electroporation (IRE) Production Mode & Process
- 12.2 Irreversible Electroporation (IRE) Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Irreversible Electroporation (IRE) Distributors
- 12.2.3 Irreversible Electroporation (IRE) Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst